A PROVEN PLATFORM.
QUALITY OUTCOMES.

Numerous clinical studies demonstrate what these leading centers already know: that the CyberKnife’s precise treatment delivery safely allows to expand radiosurgery indications.

  • Content Types

  • Indications

Found 23 Results
Page 1 of 3

CASE STUDY

Huashan Hospital CyberKnife® Center

The Huashan CyberKnife Center was one of the earliest Accuray Education Centers in China because of the willingness and expertise of the staff to share the experience.


CASE STUDY

Partial Breast Irradiation After Lumpectomy

CyberKnife radiosurgery, in conjunction with Synchrony® Respiratory Tracking, precisely delivers the prescription dose over a much shorter course of treatment than conventional radiotherapy.


CASE STUDY

Robotic IMRT Treatment of Prostate Cancer

The ability to track and correct for prostate movements during treatment reduced uncertainty in target location, thereby allowing smaller treatment volumes than those possible using conventional IMRT systems.


CASE STUDY

Ocular Lymphoma

CyberKnife radiosurgery was recommended to provide rapid regression and to maximize the opportunity for local control within the right orbit while minimizing any damage to the optic nerve and other critical structures.


CASE STUDY

Medically Inoperable Primary Liver Carcinoma

After 9 months the tumor continued to be PET-CT negative and there were no noted side effects from the treatment.


CASE STUDY

Low-Risk Organ-Confined Prostate Cancer

CyberKnife monotherapy produced an early and stable reduction in PSA in a patient with low-risk organ-confined prostate cancer with minimal acute urinary toxicities and no noted chronic toxicities.


CASE STUDY

Pancreatic Adenocarcinoma

The CyberKnife is well-poised to improve the local control rates−this is accomplished with high doses per fraction delivered via a highly conformal approach; improvements in systemic therapy are also necessary, which can easily be sequenced into the treatment as the CyberKnife treatment is of short duration.


CASE STUDY

CyberKnife® Monotherapy for Low-Risk Prostate Cancer

The CyberKnife® System successfully reproduced an HDR-like dose distribution, delivering treatment in a minimally invasive fashion.


CASE STUDY

Spinal Arteriovenous Malformation

The patient was considered to be inoperable, and was referred by the neurosurgeon for radiosurgery using the CyberKnife® Robotic Radiosurgery System.


CASE STUDY

Recurrent Multiple Myeloma at Clivius & C1

CyberKnife® treatments, with sub-millimeter accuracy and highly conformal dosimetry, was the only reasonable option to control the patient’s tumor without causing undue radiation-induced toxicity.


Start typing and press Enter to search

Send this to a friend